Correction of a pathogenic gene mutation in human embryos
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline editing has been used for years in animals, including mice, rats, monkeys and many others, and experiments show that it can be done in both nonviable or viable human embryos as well 110-113 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [112]
In the citing paper
“Of the studies that have been conducted, the reported efficiencies of repair with templates in human embryos are very low (5,7,8).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Orthwein, A. et al. Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science 344, 189–193 (2014)”
Cited work 10.1126/science.1248024 · retracted 2025-01-09 · notice 10.1126/science.adv1263 · this paper published 2017-08
Citations
Cites
1 retracted
Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions
Orthwein, A., Fradet-Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano-Diaz, C., & Durocher, D. (2014) · Science · doi:10.1126/science.1248024 · Cited by 319
RetractedA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Self-citationAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 501–600 of 948
Role for the longevity protein SIRT6 in primate development
Naiman, S., & Cohen, H. Y. (2018) · Nature · doi:10.1038/d41586-018-05970-9 · Cited by 8
Local transgene expression and whole‐body transgenesis to model brain diseases in nonhuman primate
Chansel‐Debordeaux, L., & Bézard, E. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12055 · Cited by 6
Ouagrham-Gormley, S. B., & Fye-Marnien, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-03053-7_12 · Cited by 9
CRISPR in medicine: applications and challenges
Sun, J., Hu, H., Cheng, Y., & Lu, X. (2020) · Briefings in Functional Genomics · doi:10.1093/bfgp/elaa011 · Cited by 10
Hypertrophic Cardiomyopathy: Is a ‘Cure’ Coming . . . Or Is It Already Here?
Maron, B. J., Rowin, E. J., & Maron, M. S. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.015 · Cited by 9
Rose, J. C., Popp, N. A., Richardson, C. D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/597849 · Cited by 8
Chakraborty, S. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9761-6 · Cited by 8
“Most studies, apart from looking at a very small subset using PCR (23 in (Ma et al. 2017), 16 in (Hay et al.”
BackgroundInfluentialArrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management
Mauriello, A., Roma, A. S., Ascrizzi, A., Molinari, R., Loffredo, F. S., D’Andrea, A., & Russo, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071835 · Cited by 10
Ferro, A., Segreti, A., Crispino, S. P., Cricco, R., Cristo, A. D., Ciancio, M., Gurrieri, F., Ussia, G. P., & Grigioni, F. (2025) · Genes · doi:10.3390/genes16070801 · Cited by 10
“…phenotype onset in MYH6 -mutated mice [154]; exon-skipping antisense oligonucleotides, tested in MYBPC3 -deficient mice to bypass frameshift mutations [155]; CRISPR/ Cas9-mediated correction, demonstrated in human zygotes; and hiPSC-derived cardiomyocytes, although with debated results [156].”
From gut to gamete: how the microbiome influences fertility and preconception health
Munyoki, S. K., Vukmer, N. A., Rios, J. M., Kallen, A. N., & Jašarević, E. (2025) · Microbiome · doi:10.1186/s40168-025-02230-7 · Cited by 11
Base editing reveals an essential role for NANOG in human embryogenesis
Bower, O. J., Orsi, A. E. R., McMahon, R., Staneva, D. P., Blagrove, J. R., Singh, K., Simon, C. S., McCarthy, A., Garcia, P., Shaikly, V., et al. (2026) · Nature · doi:10.1038/s41586-026-10792-1 · Cited by 10
At Last: Gene Editing in Human Embryos to Understand Human Development
Ruzo, A., & Brivanlou, A. H. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.008 · Cited by 11
“…gene-editing in human embryos had already been reported in a few other instances (Kang et al., 2016; Li et al., 2017; Liang et al., 2015; Ma et al., 2017; Tang et al., 2017), but in all cases gene-editing was used to correct genetic mutations, not as ameans to gain fundamental knowledge…”
BackgroundInfluentialThe Future of CRISPR Applications in the Lab, the Clinic and Society
Hough, S. H., & Ajetunmobi, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_9 · Cited by 8
High-accuracy crRNA array assembly strategy for multiplex CRISPR
Zhao, X., Yang, L., Li, P., Cheng, Z., Jia, Y., Luo, L., Bi, A., Xiong, H., Zhang, H., Xu, H., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102428 · Cited by 9
Parenting in the Age of Preimplantation Gene Editing
Klipstein, S. (2017) · The Hastings Center Report · doi:10.1002/hast.792 · Cited by 7
“Earlier this year, scientists announced that they had used this technique to repair a gene in several dozen early embryos carrying a mutation known to cause hypertrophic cardiomyopathy.(9) If transferred to the uterus, such an embryo would result not only in the birth of a child whose DNA does not carry the mutation l…”
MethodBraun, M., & Meacham, D. (2019) · EMBO Reports · doi:10.15252/embr.201847583 · Cited by 8
“But this agreement has come under pressure, in large part because of further research that demonstrated the feasibility of correcting mutations in human embryos [4] as well as institutional statements that seem to soften the stance against reproductive germline editing [5].”
BackgroundSakamoto, T., & Sakamoto, H. (2019) · Nutrients · doi:10.3390/nu11030611 · Cited by 8
“This technology has been used in several species and may improve knowledge of corticosteroid signaling in human nutrition metabolism [59,60].”
MethodPharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathy
Spoladore, R., Fragasso, G., Pannone, L., Slavich, M., & Margonato, A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1702023 · Cited by 7
Impacts of oocyte/zygote timing for in vitro fertilization and gene editing in the dog
Mukai, C., Nelson, J. L., Cheong, S. H., de Amorim, M. D., & Travis, A. J. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.02.003 · Cited by 8
Chinnasamy, D., Janakiraman, U., Moutal, A., Fukunaga, K., Khanna, R., & Nelson, M. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105224 · Cited by 7
Improving CRISPR-Cas9 mediated genome integration in interspecific hybrid yeasts.
Bennis, N., Kostanjšek, M., van den Broek, M. A., & Daran, J. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.04.001 · Cited by 8
Advances in symptomatic therapy for left ventricular non-compaction in children
Li, D., & Wang, C. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1147362 · Cited by 10
“Further, the ability to obtain LVNC animal models provides greater opportunities for treatment experimentations, including the possibility of preventing or eliminating LVNC by means of gene knockout or mutant gene repair, which should be gradually considered (113).”
BackgroundCommunicating Biotech Advances: Fiction versus Reality
Małyska, A., Bolla, R. I., & Twardowski, T. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.10.018 · Cited by 7
Structural insights into the apo-structure of Cpf1 protein from Francisella novicida
Min, K.-J., Yoon, H., Jo, I., Ha, N., Jin, K. S., Kim, J., & Lee, H. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.057 · Cited by 7
Self-citationGenome editing technologies and their potential to treat neurologic disease
Madigan, N. N., Staff, N. P., Windebank, A. J., & Benarroch, E. E. (2017) · Neurology · doi:10.1212/wnl.0000000000004558 · Cited by 7
“The recent publication of a gene editing study in human embryos that demonstrated the correction of a MYBPC3 gene mutation, which causes hereditary hypertrophic cardiomyopathy, demonstrates that such research has accelerated, with surrounding academic controversy.(63)”
BackgroundSripaurya, B., Pelyuntha, W., Ngasaman, R., Ching, C. L., Guyonnet, V., & Vongkamjan, K. (2025) · Research in Veterinary Science · doi:10.1016/j.rvsc.2025.105891 · Cited by 7
Doubts raised about CRISPR gene-editing study in human embryos
Callaway, E. (2017) · Nature · doi:10.1038/nature.2017.22547 · Cited by 6
Pasqua, T., Tropea, T., Granieri, M. C., Bartolo, A. D., Spena, A. R., Moccia, F. D., Rocca, C., & Angelone, T. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107003 · Cited by 6
Is Editing the Genome for Climate Change Adaptation Ethically Justifiable?
Lehmann, L. S. (2017) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2017.19.12.stas1-1712 · Cited by 6
Clinical and Molecular Aspects of Cardiomyopathies
Maurizi, N., Ammirati, E., Coppini, R., Morrone, A., & Olivotto, I. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.01.001 · Cited by 9
Cussins, J., & Lowthorp, L. (2018) · The New Bioethics · doi:10.1080/20502877.2018.1443409 · Cited by 9
“This statistic has been repeated in a number of news articles and commentaries over the years (Sample 2015).9 Although around one in 200 people have mutations in their mitochondrial DNA, only around one in 5,000 people have mitochondrial disease (Mitalipov and Wolf 2014).”
Background#CRISPRfacts, Gene Editing, and Joking in the Twittersphere
Lowthorp, L. (2018) · Journal of American Folklore · doi:10.5406/jamerfolk.131.522.0482 · Cited by 6
Ethik: Reproduktionsmedizin unter dem Aspekt ethischer Normen und des Kindeswohls
Kreß, H. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57636-6_57 · Cited by 6
CRISPR/Cas9 in Male Factor Infertility
Cina, D., Phillips, D., & Flannigan, R. K. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00011-y · Cited by 7
Cas9 in Human Embryos: On Target but No Repair
Hoffmann, E. R., & Roig, I. (2020) · Cell · doi:10.1016/j.cell.2020.11.022 · Cited by 6
Human embryo genome editing: an interdisciplinary approach
Grebenshchikova, E. G., Andreyuk, D., Volchkov, P., Vorontsova, M. V., Ginter, E. K., Izhevskaya, V. L., Lagunin, A. A., Polyakov, A. V., Popova, O. V., Smirnikhina, S., et al. (2021) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1269 · Cited by 7
Genomic Politics: How the Revolution in Genomic Science Is Shaping American Society
Hochschild, J. L. (2021) · doi:10.1093/oso/9780197550731.001.0001 · Cited by 7
Origin of the genome editing systems: application for crop improvement
Viviani, A., Spada, M., Giordani, T., Fambrini, M., & Pugliesi, C. (2022) · Biologia · doi:10.1007/s11756-022-01142-3 · Cited by 6
“2017) First time used the CRISPR/Cas9 successfully edited the mutations in human embryos (Ma et al. 2017) In Haloferax mediterranei, sequences repeated at regular interval were found (Juez et al.”
MethodRetained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos
Bekaert, B., Boel, A., Witte, L. D., Vandenberghe, W., Popovic, M., Stamatiadis, P., Cosemans, G., Tordeurs, L., Loore, A. M. D., Lopes, S. M. C. D. S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.06.013 · Cited by 7
Unmet needs and future directions in hypertrophic cardiomyopathy
Kaur, S., & Desai, M. Y. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.08.001 · Cited by 6
TIGER: Single-step in vivo genome editing in a non-traditional rodent
Li, S., Mereby, S. A., Rothstein, M., Johnson, M. R., Brack, B. J., & Mallarino, R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112980 · Cited by 7
“29,39,40 Moreover, as evidenced by reports in mice, 41 rats, 42 and hamsters, 43 rodents have a major wave of zygotic genome activation (ZGA) that occurs in 2-cell embryos, which slows the cell cycle and introduces a long G2 pause.”
Yang, H., Liu, Y., Yang, Y., Li, D., & Wang, Z. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad318 · Cited by 7
Chinese scientists fix genetic disorder in cloned human embryos
Cyranoski, D. (2017) · Nature · doi:10.1038/nature.2017.22694 · Cited by 6
Recent Advances in Therapeutic Genome Editing in China
Yang, Y., Wang, Q., Li, Q., Men, K., He, Z., Deng, H., Ji, W., & Wei, Y. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.210 · Cited by 6
Symposium review: Embryo survival—A genomic perspective of the other side of fertility
Khatib, H., & Gross, N. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-15252 · Cited by 8
Human embryo gene editing: God's scalpel or Pandora's box?
Zhou, Q., Zhang, Y., Zou, Y., Yin, T., & Yang, J. (2020) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz025 · Cited by 9
Efficient SNP editing in haploid human pluripotent stem cells
Safier, L. Z., Zuccaro, M. V., & Egli, D. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01723-8 · Cited by 7
Single Cell Genetics and Epigenetics in Early Embryo: From Oocyte to Blastocyst
Wei, Y., Zhang, H., Wang, Q., & Zhang, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0502-3_9 · Cited by 6
Historical Perspectives in the Evolution of Hypertrophic Cardiomyopathy
Panza, J. A., & Naidu, S. S. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2018.08.001 · Cited by 8
A Metric Approach to Hot Topics in Biomedicine via Keyword Co-occurrence
Qin, J. H., Wang, J. J., & Ye, F. Y. (2019) · Journal of Data and Information Science · doi:10.2478/jdis-2019-0018 · Cited by 6
“The group of Ma et al. (2017) describe the correction of a pathogenic gene mutation in human embryos with CRISPR/Cas9.”
What would responsible remedial human germline editing look like?
Adashi, E. Y., & Cohen, I. G. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0482-7 · Cited by 7
The state of the art in stem cell biology and regenerative medicine: the end of the beginning
Snyder, E. Y. (2017) · Pediatric Research · doi:10.1038/pr.2017.258 · Cited by 7
Correction of a Recessive Genetic Defect by CRISPR-Cas9-Mediated Endogenous Repair
Susani, L., Castelli, A., Lizier, M., Lucchini, F., Vezzoni, P., & Paulis, M. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0004 · Cited by 8
“8 A role for inter-homologue repair was suggested, although this interpretation has been challenged.”
Cleavage and Gastrulation in the Mouse Embryo
Nahaboo, W., & Migeotte, I. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0001068.pub3 · Cited by 7
The evolution of preimplantation genetic testing: where is the limit?
Capalbo, A., & Wells, D. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104845 · Cited by 6
Investigation of BAK, BAX and MAD2L1 gene expression in human aneuploid blastocysts
Ahmed, M., Aytacoglu, H., Coban, Ö., & Tulay, P. (2023) · Zygote · doi:10.1017/s0967199423000539 · Cited by 5
Hilbert, L., Gadzekpo, A., Vecchio, S. L., Wellhäusser, M., Tschurikow, X., Prizak, R., Becker, B., Burghart, S., & Oprzeska‐Zingrebe, E. A. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15415 · Cited by 8
“Lastly, even the human genetic code has been manipulated in a targeted fashion, tackling disease-causing code errors 7 and raising fundamental ethical questions.”
Edited course of biomedical research: leaping forward with CRISPR
Collins, P. J., Hale, C. M., & Xu, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.008 · Cited by 7
Autonomy in Tension: Reproduction, Technology, and Justice
King, L. P., Zacharias, R. L., & Johnston, J. (2017) · The Hastings Center Report · doi:10.1002/hast.788 · Cited by 5
Outer Limits of Biotechnologies: A Jewish Perspective
Loike, J. D., & Kadish, A. H. (2018) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10328 · Cited by 6
“Rambam Maimonides Medical Journal, 9(1), [Article e0008].”
Genome Editing: Promoting Responsible Research
Hirsch, F., Lemaitre, C., Chneiweiss, H., & Montoliu, L. (2019) · Pharmaceutical Medicine · doi:10.1007/s40290-019-00276-1 · Cited by 5
Therapeutic Germline Editing: Sense and Sensibility
Adashi, E. Y., & Cohen, I. G. (2020) · Trends in Genetics · doi:10.1016/j.tig.2019.12.011 · Cited by 6
Heredity and segregation of mtDNA
Burr, S. P., & Chinnery, P. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819656-4.00004-8 · Cited by 7
Experimental Model of Cardiotoxicity
Erbaş, O., Altuntaş, İ., Çağlar, Ö., Özyılmaz, E., Sari, E., Üzümcü, İ., & Erbakan, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101401 · Cited by 6
“[168] Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K, et al.”
BackgroundMethodCRISPR-CAS UYGULAMALARI, POTANSİYEL RİSKLER VE YASAL DÜZENLEMELER
TOSUN, Ö. K., & Kesmen, Z. (2022) · Helal ve Etik Araştırmalar Dergisi · doi:10.51973/head.1209563 · Cited by 7
Moradbeigi, P., Hosseini, S., Salehi, M., & Mogheiseh, A. (2024) · Biological Procedures Online · doi:10.1186/s12575-024-00230-9 · Cited by 6
“It has been reported that injection of RNP in conjunction with sperm in the matured oocyte resulted in a single mutant embryo [72].”
BackgroundCRISPR-Cpf1 system and its applications in animal genome editing
Han, Y., Jia, Z., Xu, K., Li, Y., Lu, S., & Guan, L. (2024) · Molecular Genetics and Genomics · doi:10.1007/s00438-024-02166-x · Cited by 6
“The traditional method of embryonic microinjection can result in a higher rate of genotypic mosaicism (Ma et al. 2017 ).”
Self-citationCRISPR–Cas becoming more human
Baumann, K. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.84 · Cited by 4
The year in cardiology 2017: heart failure
Lund, L. H., Køber, L., Swedberg, K. B., & Ruschitzka, F. T. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx782 · Cited by 5
“to edit hypertrophic cardiomyopathy causing genes in human embryos.(89)”
Preventing Mitochondrial Disease
Adashi, E. Y., & Cohen, I. G. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002486 · Cited by 5
CRISPR's Twisted Tales: Clarifying Misconceptions about Heritable Genome Editing
Darnovsky, M., & Hasson, K. (2020) · Perspectives in biology and medicine · doi:10.1353/pbm.2020.0012 · Cited by 11
“QUEM MERECE VIVER E QUEM MERECE MORRER”: DILEMAS ÉTICOS EM TEMPOS DE PANDEMIA DA COVID-19
Westphal, E. R. (2020) · Estudos Teológicos · doi:10.22351/et.v60i2.4076 · Cited by 5
Farris, M., Texter, P. A., Mora, A. A., Wiles, M. V., Garrigle, E. F. M., Klaus, S. A., & Rosfjord, K. M. (2020) · BMC Genomics · doi:10.1186/s12864-020-07233-2 · Cited by 5
Silva, S., de Freitas, C., Severo, M., & Silva, S. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02569-y · Cited by 6
Geuverink, W. P., van El, C. G., Cornel, M. C., Peerbolte, L. J. L., der Wal, J. T. G.-V., & Martin, L. (2023) · Humanities and Social Sciences Communications · doi:10.1057/s41599-023-01935-0 · Cited by 6
CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation
Ma, L., Jang, L., Chen, J., Song, J. W., Yang, D., Zhang, J., Chen, Y. E., & Xu, J. (2019) · Journal of Visualized Experiments · doi:10.3791/59512 · Cited by 5
Springer, C., Wolf, E., & Simmet, K. (2021) · Journal of Developmental Biology · doi:10.3390/jdb9020015 · Cited by 5
“Injection of CRISPR/Cas into M-phase oocytes concurrent with ICSI can increase editing efficiency and reduce mosaicism in mouse and human embryos [121].”
BackgroundStrategies and mechanisms of precision genome engineering: From gene editing to genome writing
Huang, K., Tian, J., Zhao, W., Zhang, S., Xiang, L., Yang, M., Ls, L., Huang, Y., Zhang, N., Sun, L., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70115 · Cited by 10
Szocik, K. (2023) · NanoEthics · doi:10.1007/s11569-023-00438-1 · Cited by 4
“One of the methods used in GGE, for both viable and nonviable human embryos, is CRISPR-Cas9 [17].”
MethodRecombinant DNA technology and gene therapy
Sivamani, Y., Hegde, S., Bhat, A. R., Sajal, H., & Elayaperumal, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16013-4.00017-8 · Cited by 4
The case for germline gene correction: state of the science
Amato, P., Mikhalchenko, A. E., & Mitalipov, S. M. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.04.039 · Cited by 5
Self-citationOptimizing gene editing in pigs: The role of electroporation and lipofection
Piñeiro-Silva, C., & Gadea, J. (2025) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2025.107874 · Cited by 4
Machine learning finds Cas9-edited genotypes
Bae, S., & Kim, J. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0327-6 · Cited by 4
Self-citationThe Regulation of Human Germline Genome Modification in Japan
Ishii, T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.017 · Cited by 4
Nogueira, G. A. D. S., Brito, A. E. D. A., do Nascimento, V. R., Albuquerque, G. D. P., do Amarante, C. B., de Oliveira, J. T., Silva, P. A., & Neto, C. F. D. O. (2022) · Bioscience Journal · doi:10.14393/bj-v38n0a2022-61137 · Cited by 6
Park, C., Jeoung, Y.-H., Zhang, L., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059710 · Cited by 4
Seven open questions in the futures of human genome editing
Nelson, J. P., & Selin, C. L. (2023) · Futures · doi:10.1016/j.futures.2023.103138 · Cited by 8
The CRISPR Revolution: Unraveling the mysteries of Life’s genetic code
Harsij, Z., Ghafoorzadeh, Z., & Goharian, E. (2023) · Gene · doi:10.1016/j.gene.2023.147870 · Cited by 6
Effects of klotho protein or klotho knockdown in porcine oocytes at different stages
Kim, E. P., Kim, D. Y., Park, C., et al. (2023) · Zygote · doi:10.1017/s096719942300045x · Cited by 4
Self-citationBekaert, B., Boel, A., Rybouchkin, A., Cosemans, G., Declercq, S., Lopes, S. M. C. D. S., Parrington, J., Stoop, D., Coucke, P. J., Menten, B., et al. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03095-9 · Cited by 4
“…suggest that a reasonable explanation for the lack of the synonymous variant in embryos solely carrying the wild-type allele could be the occurrence of other mechanisms following DSB, such as gene conversion [6, 8, 9, 19, 21] or the partial/complete loss of the mutant chromosome [7, 22, 24].”
InfluentialModelos tridimensionais de cultura de células: aproximando o in vitro do in vivo
Cavalheiro, M., de Barros, A. P. D. N., Louback, R. D. A., & Rossi, M. I. D. (2018) · Vigilância Sanitária em Debate · doi:10.22239/2317-269x.01047 · Cited by 10
Nonviral Gene Therapy: Design and Application of Inorganic Nanoplexes
Viñambres, M., Dominguez, A. L., Portolés, M. T., Serrano, M. C., & Marciello, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00011-3 · Cited by 7
Disruptive Synergy: Melding of Human Genetics and Clinical Assisted Reproduction
Adashi, E. Y., & Cohen, I. G. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100093 · Cited by 4
“Editing at the time of fertilization gave rise to an overall targeting efficiency of 72%.(42) Note was also made of insertions, deletions, and mosaicism, which highlight the formidable technical impediments that must be negotiated for remedial germline editing to become a reality.”
BackgroundPreimplantation Genetic Testing
Yatsenko, S. A., & Rajkovic, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815236-2.00007-2 · Cited by 5
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
van Essen, M. J., Riepsaame, J., & Jacob, J. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0063 · Cited by 5
“Base editing also operates in nondi-viding cells that are refractory to DSB-stimulated HDR. Base editing is functional in hiPSC, with the caveat that only a few studies have been published to date.”
InfluentialGutierrez, K., Glanzner, W. G., de Macedo, M. P., Rissi, V. B., Dicks, N., Bohrer, R. C., Baldassarre, H., Agellon, L. B., & Bordignon, V. (2022) · Life · doi:10.3390/life12020171 · Cited by 5
“Moreover, it appears that homologous repair (HR) is favored and mosaicism rates are reduced when injections are performed at metaphase II oocytes or at the two-cell stage as compared to zygotes [23,24].”
BackgroundResultInfluentialHypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline
Tamargo, J. L., Tamargo, M., & Caballero, R. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2113374 · Cited by 5
“Genome editing CRISPR associated protein 9 (CRISPR/ Cas9) system Induces sequence-specific DNA double-strand breaks which are repaired by homology-directed repair using single-strand oligonucleotides or double-strand DNA donors Corrects HCM caused by a GAGT-deletion in exon 16 of the MYBPC3 gene in HCM hiPSC-CMs and h…”
MethodMaron, B. J., Maron, M. S., Sherrid, M. V., Ommen, S. R., & Rowin, E. J. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.07.033 · Cited by 5
Editing the human genome: where ART and science intersect
Hershlag, A., & Bristow, S. L. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1219-0 · Cited by 7
“Very recently, the findings from Ma et al. (2017) have come under close scrutiny, with skepticism to the claim that injection of gene-editing machinery into the oocyte that the same time of the sperm eliminates mosaicism and offtarget affects.”
BackgroundNowlin, C. (2018) · Perspectives in biology and medicine · doi:10.1353/pbm.2018.0054 · Cited by 4
Metadata
- Authors
- Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., Darby, H., Van Dyken, C., Li, Y., Kang, E., Park, A.-R., Kim, D., Kim, S.-T., Gong, J., Gu, Y., Xu, X., Battaglia, D., Krieg, S. A., Lee, D. M., Wu, D. H., Wolf, D. P., Heitner, S. B., Belmonte, J. C. I., Amato, P., Kim, J.-S., Kaul, S., & Mitalipov, S.
- Affiliations
- Oregon Health & Science University (US)
- Institute for Basic Science (KR)
- Salk Institute for Biological Studies (US)
- Seoul National University (KR)
- BGI Group (China) (CN)
- Corresponding author
- Amato, Paula
- Kim, Jin-Soo
- Kaul, Sanjiv
- Mitalipov, Shoukhrat
- ORCID
- Venue
- Nature
- Published
- 2017-08
- Volume
- 548
- Issue
- 7668
- Pages
- 413-419
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2740810575
- Cited by
- 992
- References
- 48
- Citations by year
- 2026: 22 · 2025: 50 · 2024: 47 · 2023: 93 · 2022: 75 · 2021: 107 · 2020: 135 · 2019: 155 · 2018: 217 · 2017: 88
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2017-10-02)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Oregon Health and Science University
- Leona M. and Harry B. Helmsley Charitable Trust
- Consorzio Interuniversitario Biotecnologie
- Moxie Foundation
- Government of Jiangxi Province
- Institute for Basic Science (IBSR021-D1, R021-D1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- germline editing, CRISPR/Cas9, MYBPC3 mutation, hypertrophic cardiomyopathy, preimplantation embryo, homology-directed repair, mosaicism, DNA double-strand break repair, cell cycle timing, preimplantation genetic diagnosis, off-target mutations
- MeSH terms
- Gene Editing, Myosin Binding Protein C, Adult, Alleles, Blastocyst, Carrier Proteins, Cell Division, Embryo, Mammalian, Genetic Complementation Test, Heterozygote, Homozygote, Humans, Male, Mosaicism, Mutation, Templates, Genetic, Zygote, S Phase, Gene Targeting, DNA Breaks, Double-Stranded, Recombinational DNA Repair, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.